Cargando…
Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from in vitro testing
Autores principales: | Savaşan, Süreyya, Gadgeel, Manisha, Freeman, Cathryn, Moussa, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614523/ https://www.ncbi.nlm.nih.gov/pubmed/35796009 http://dx.doi.org/10.3324/haematol.2022.280895 |
Ejemplares similares
-
Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells
por: Savaşan, Süreyya, et al.
Publicado: (2023) -
Osteoclastogenesis inhibition by mutated IGSF23 results in human osteopetrosis
por: Yuan, Ying, et al.
Publicado: (2019) -
Unusual Cortical Phenotype After Hematopoietic Stem Cell Transplantation in a Patient With Osteopetrosis
por: Afshariyamchlou, Sonia, et al.
Publicado: (2022) -
Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases
por: Even-Or, Ehud, et al.
Publicado: (2022) -
Allogeneic hematopoietic stem-cell transplantation for
myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)